Articles with the keyword: 


The Case of the Telltale Fingertips
jerry submitted, created time 5 months 3 weeks (sciencenow.sciencemag.org)
Club-shaped fingers can be a warning sign for serious lung and heart conditions, but the cause of the disorder has remained a mystery for more than 2400 years. Now, researchers may have taken a step toward solving the puzzle by pinpointing the mutation that spurs a rare type of clubbing... 
Rosiglitazone-Associated Fractures in Type 2 Diabetes
jerry submitted, created time 6 months 1 week (care.diabetesjournals.org)
This is an analysis from a diabetes outcome progression trial.
It said that further investigation into the risk factors and underlying pathophysiology for the increased fracture rate in women taking rosiglitazone is required to relate them to preclinical data and better understand the clinical implications of and possible interventions for these findings 


Notch controls bone formation and strength
jane2007 submitted, created time 8 months 3 weeks (www.bcm.edu)
Notch, a protein known to govern the determination of cell differentiation into different kinds of tissues in embryos, plays a critical role in bone formation and strength later in life. These findings may provide a basis for understanding osteoporosis and diseases in which there is too much bone. 


TB-scarred Homo erectus skull found in Turkey
Darkfrog submitted, created time 11 months 3 days (www3.interscience.wiley.com)
The article discusses the way in which TB affected migrating populations. According to the article, examination of this skull supports the idea that as dark-skinned hominids moved into areas where the sun was less intense, they found themselves deficient in vitamin D, which affected their bones and immune systems.
It also got a writeup in the New York Times.
http://www.nytimes.com/2007/12/18/science/18skul.html?ref=science 


Denosumab fortifies bone in breast cancer patients
Eric wu submitted, created time 11 months 3 days (www.reuters.com)
The osteoporosis drug denosumab increased bone strength in women receiving hormone therapy for breast cancer, drug maker Amgen Inc said Friday. 
\ 1
\